EUVIMEDEUVIMED entdecken
Crossref

Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease

Suurya Krishnan, Wan C Tan, Raquel Farias, Shawn D Aaron, Andrea Benedetti, Kenneth R Chapman, Paul Hernandez, François Maltais, Darcy D Marciniuk, Denis E O'Donnell, Don D Sin, Brandie Walker und 2 weitere

CHEST · 2023-09 · 164 (3) · 637-649

DOI: 10.1016/j.chest.2023.02.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CHEST, 2023-09. Verfasst von Suurya Krishnan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Epidemiology and Clinical Research Unit, Center of Outcome Research and Evaluation, Research Institute of the McGill University Health Ce…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Pulmonary Disease, Chronic Obstructive, Myocardial Ischemia. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: CIHR, Canadian Institutes of Health Research, AstraZeneca Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesPulmonary Disease, Chronic ObstructiveMyocardial IschemiaHumansCohort StudiesForced Expiratory VolumeCanadaRisk FactorsSpirometry

Stichwörter der Autor:innen

COPDFramingham risk scorecardiovascular diseaseheart failureischemic heart diseasepooled cohorts’ equationpreserved ratio impaired spirometry

Autor:innen und Institutionen

  • Respiratory Epidemiology and Clinical Research Unit, Center of Outcome Research and Evaluation, Research Institute of the McGill University Health Centre, McGill University, Montreal, ON Canada.
  • Center for Heart Lung Innovation, University of British Columbia and St. Paul's Hospital, Vancouver, BC, Canada.
  • Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
  • Toronto General Hospital Research Institute, University of Toronto, Toronto, ON, Canada.
  • Division of Respirology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.
  • Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, Canada.

Förderung

  • CIHR
  • Canadian Institutes of Health Research
  • AstraZeneca Canada
  • Reseau canadien de recherche respiratoire
  • Fonds de Recherche du Québec - Santé
  • Novartis
  • McGill University
  • McGill University Health Centre

Zitieren

APA

Krishnan, S., Tan, W. C., Farias, R., Aaron, S. D., Benedetti, A., Chapman, K. R., Hernandez, P., Maltais, F., Marciniuk, D. D., O'Donnell, D. E., Sin, D. D., Walker, B., Bourbeau, J., & Canadian Cohort Obstructive Lung Disease Collaborative Research Group and the Canadian Respiratory Research Network (2023). Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease. CHEST, 164(3), 637-649. https://doi.org/10.1016/j.chest.2023.02.045

Vancouver

Krishnan S, Tan WC, Farias R, Aaron SD, Benedetti A, Chapman KR, et al. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease. CHEST. 2023;164(3):637-649. doi:10.1016/j.chest.2023.02.045

BibTeX
@article{Krishnan2023,
  author = {Krishnan, Suurya and Tan, Wan C and Farias, Raquel and Aaron, Shawn D and Benedetti, Andrea and Chapman, Kenneth R and Hernandez, Paul and Maltais, François and Marciniuk, Darcy D and O'Donnell, Denis E and Sin, Don D and Walker, Brandie and Bourbeau, Jean and Canadian Cohort Obstructive Lung Disease Collaborative Research Group and the Canadian Respiratory Research Network, Canadian Cohort Obstructive Lung Disease Collaborative Research Group and the Canadian Respiratory Research Network},
  title = {Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease},
  journal = {CHEST},
  year = {2023},
  volume = {164},
  number = {3},
  pages = {637--649},
  doi = {10.1016/j.chest.2023.02.045}
}
Kostenlos starten →